Cholesterol Testing: Global Strategic Business Report

Report
273 Pages
April 2024
Region: Global
Global Industry Analysts, Inc
ID: 338881

Global Cholesterol Testing Market to Reach $31.7 Billion by 2030

The global market for Cholesterol Testing estimated at US$22 Billion in the year 2022, is projected to reach a revised size of US$31.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2022-2030. Diagnostic Centers, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$11.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Physicians / Providers & Hospitals segment is readjusted to a revised 4.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6.4 Billion, While China is Forecast to Grow at 8% CAGR

The Cholesterol Testing market in the U.S. is estimated at US$6.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.9 Billion by the year 2030 trailing a CAGR of 8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 5.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.4 Billion by the year 2030.

Select Competitors (Total 42 Featured) -

Abbott Laboratories
AccuTech LLC
Akers Biosciences Inc.
Beckman Coulter Inc.
Bio-Rad Laboratories Inc.
Boston Heart Diagnostics Corporation
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Home Access Health Corporation
Laboratory Corporation of America® Holdings
PTS Diagnostics
Quest Diagnostics Inc.
Randox Laboratories Ltd.
Sekisui Diagnostics LLC
Siemens Healthineers
Sigma-Aldrich Corp.

What's New?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Cholesterol Testing - An Overview
Recent Market Activity
Prevailing Scenario in the Global Healthcare Sector Favors Market Growth
Increasing Healthcare Expenditure
Wider Availability of Healthcare & Diagnostics Services
Growing Health-Consciousness
Lenience Towards Preventive Care
Cholesterol Testing - Global Key Competitors Percentage Market Share in 2022 (E)
Developed Regions Remain Key Revenue Contributors
Developing Economies Offer Significant Potential
Key Factors Driving Demand for Healthcare Services in Developing Regions
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

Abbott Laboratories (USA)
AccuTech, LLC (USA)
Akers Biosciences, Inc. (USA)
Beckman Coulter, Inc. (USA)
Bio-Rad Laboratories, Inc. (USA)
Eurofins Scientific (Luxembourg)
Boston Heart Diagnostics Corporation (USA)
F. Hoffmann-La Roche Ltd. (Switzerland)
Home Access Health Corporation (USA)
Laboratory Corporation of America® Holdings (USA)
PRIMA Lab SA (Switzerland)
PTS Diagnostics (USA)
Quest Diagnostics, Inc. (USA)
Randox Laboratories Ltd. (UK)
Sekisui Diagnostics, LLC (USA)
Siemens Healthineers (Germany)
Sigma-Aldrich Corp. (USA)

3. MARKET TRENDS & DRIVERS

Growing Prevalence of Cardiovascular Disease Steers Cholesterol Testing Volumes
Global Menace of Cardiovascular Disease: Quick Facts
A Brief Overview of Select Cholesterol-Driven Cardiac Disorders
Coronary Artery Disease
Hyperlipidaemia
CVD Statistics
Risk of CVD in Obese People Underpins Cholesterol Testing Volumes
Global Obesity Facts in a Nutshell
Cholesterol Screening Assumes Importance in Diabetes Care
Global Diabetes Expenditure: Opportunity Indicator
The Hypertension-Cholesterol Link Accelerates the Need for Cholesterol Screening
Aging Population - A Vital Demography
Uptrend in In-Vitro Diagnostics (IVD) Sector Signals Prospects
Healthy Growth in Cardiac IVD Market Augments Market Potential
Positive Momentum in Point of Care (POC) Diagnostics Generates Parallel Opportunities
POC Diagnostics - An Overview
POC Cholesterol Testing Makes Rapid Gains
Massive Demand for Lipid Panel/Lipid Profile Tests
Northbound Trajectory in POC LPT Services
Rise of C-reactive Protein Tests to Aid Market Growth
Cholesterol Testing: Evolution from Invasive to Non-Invasive
Recent Breakthroughs in Non-Invasive Cholesterol Testing Domain
Nonfasting Lipid Testing Invalidates the Need for Pre-Test Fasting
Cloud Screening Platforms Extend New Level of Convenience
Self-Testing Kits: An Emerging Issue for Full-Scale Services Providers
A Rapidly Evolving Market Enabled by Technology
Opportunities & Challenges in Self-Testing Industry
E-Retailing Drives Sales of Home Test Kits
A Brief Overview of Select Cholesterol Test Kits

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 3: World 18-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 6: World 18-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for Physicians / Providers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Physicians / Providers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 9: World 18-Year Perspective for Physicians / Providers & Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for Government Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Government Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 12: World 18-Year Perspective for Government Agencies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
Table 13: World Cholesterol Testing Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

UNITED STATES

Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
Table 14: USA Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 15: USA Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 16: USA 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

CANADA

Table 17: Canada Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 18: Canada Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 19: Canada 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

JAPAN

Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 20: Japan Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 21: Japan Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 22: Japan 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

CHINA

Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 23: China Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 24: China Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 25: China 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

EUROPE

Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 26: Europe Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 27: Europe Historic Review for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 28: Europe 18-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
Table 29: Europe Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 30: Europe Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 31: Europe 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

FRANCE

Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 32: France Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 33: France Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 34: France 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

GERMANY

Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 35: Germany Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 36: Germany Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 37: Germany 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

ITALY

Table 38: Italy Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 39: Italy Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 40: Italy 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

UNITED KINGDOM

Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 41: UK Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 42: UK Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 43: UK 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

SPAIN

Table 44: Spain Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 45: Spain Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 46: Spain 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

RUSSIA

Table 47: Russia Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 48: Russia Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 49: Russia 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

REST OF EUROPE

Table 50: Rest of Europe Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 51: Rest of Europe Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 52: Rest of Europe 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

ASIA-PACIFIC

Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 54: Asia-Pacific Historic Review for Cholesterol Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 55: Asia-Pacific 18-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 57: Asia-Pacific Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
Table 58: Asia-Pacific 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

AUSTRALIA

Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)

INDIA

Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)

SOUTH KOREAREST OF ASIA-PACIFIC

LATIN AMERICA

Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)

ARGENTINABRAZILMEXICOREST OF LATIN AMERICA

MIDDLE EAST

Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)

IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST

AFRICA

Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott Laboratories
AccuTech LLC
Akers Biosciences Inc.
Beckman Coulter Inc.
Bio-Rad Laboratories Inc.
Boston Heart Diagnostics Corporation
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Home Access Health Corporation
Laboratory Corporation of America® Holdings
PTS Diagnostics
Quest Diagnostics Inc.
Randox Laboratories Ltd.
Sekisui Diagnostics LLC
Siemens Healthineers
Sigma-Aldrich Corp.

Table Information

Report Attribute	Details
No. of Pages	273
Published	April 2024
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 22 Billion
Forecasted Market Value ( USD ) by 2030	$ 31.7 Billion
Compound Annual Growth Rate	4.7%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5303EUR$5,450USD£4,543GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10075EUR$10,355USD£8,631GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15908EUR$16,350USD£13,628GBP

Global Cholesterol Testing Market to Reach $31.7 Billion by 2030

The U.S. Market is Estimated at $6.4 Billion, While China is Forecast to Grow at 8% CAGR

Select Competitors (Total 42 Featured) -

What's New?

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Cholesterol Test Global Market Report 2024

Global Cholesterol Testing Products & Services Market by Offering (Product, Services), Test Type (High-Density Lipoprotein Cholesterol Test, Low-Density Lipoprotein Cholesterol Test, Total Cholesterol Test), Age Group, End-Users - Forecast 2024-2030

Global Cholesterol Testing Products & Services Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Cholesterol Testing Market by Product Type (Test Kits, Testing Strips), Test (High-Density Lipoprotein, Low-Density Lipoprotein, Total Cholesterol Test), Test Type, Prescription Mode, End-Users - Forecast 2024-2030

Lipid Panel Testing Global Market Report 2024

About the Cholesterol Testing Market